Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check4 days agoChange DetectedA new history entry Revision: v3.3.3 was added, and the HHS Vulnerability Disclosure link along with the previous Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page history shows a revision bump from v3.2.0 to v3.3.2, a metadata update with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedDeletion removes an administrative notice about government funding and operating status, which does not affect trial data or the page's core purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedA new history entry (Version 77, 2025-10-17) was added, updating the Study Status. This reflects the latest status for the study in the record.SummaryDifference0.0%

- Check68 days agoChange Detected- Added a current date (2025-10-20) and a new study status entry (2025-10-17). - Removed an outdated date (2025-08-01).SummaryDifference0.7%

- Check82 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference8%

Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.